...This board is full of derampers just after making a few quid shorting the stock. Ignore and hopefully they will get burnt when a partnership is announced and the sp recovers. In the meantime buy on the lows. Best wishes. Freddie p's nothing personal, just business
Guys, this is just the beginning of whole bunch of good news. Last week a new stockholder has entered the building. We know already from others Sareums Skill platform will be worth a lot >5P so just wait and see.
Where do you get the idea this is a "no news RNS"? For a start this is not an RNS, it is simply announcing a peer-reviewed journal article published today. And what's not to like about a team of scientists reporting a striking decrease in disease pathology thanks to Sareum's compound SAR-20347? To me that sounds like good news for the millions of people with psoriasis, for which there is currently no effective treatment.
It's the market who decides price( meant to anyway) all I'm saying is the expectation of really good news means that a no news RNS makes the market believe that nothing really positive will happen any day soon and pushes out the pay day. Rightly or wrongly there is lots of negativity around sareum
Taking a somewhat longer-term view than the first hour's trading, note what the Journal of Immunology says: "the administration of SAR-20347 led to a striking decrease in disease pathology". For a scientist, a phrase such as "striking decrease" is pretty exciting language!
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.